Abstract

The study was an initial exploration of the current ototoxicity assessment and management practices by audiologists in South Africa. An exploratory survey research methodology through a cross-sectional research design was adopted where audiologists were recruited from professional associations’ databases in South Africa, using specific inclusion criteria. The study made use of an 18-item web-based survey guided by the Health Professions Council of South Africa (HPCSA) (2018) guidelines which were developed from reviewing international guidelines such as the American Speech-Language-Hearing Association (ASHA,1994) and the American Academy of Audiology (AAA, 2009). The study surveyed 31 audiologists from across the country. Data were analyzed through descriptive statistics. Findings implied significant gaps between knowledge and translation of this knowledge into practice. Over two thirds of the participants engage with ototoxicity monitoring and management, but the practices adopted by them do not align with international standards nor with the national HPCSA guidelines on assessment and management of patients on ototoxic medications. Most participants do not conduct baseline assessments, and the frequency of monitoring is irregular and reduced from the recommended; thus influencing ability for early detection and intervention of ototoxicity within this context. Non-standard assessment battery is used for assessment and monitoring, raising questions about the reliability and validity of the data used to make preventive treatment decisions. Lack of collaborative work between audiologists and the rest of the clinical team involved in the treatment of patients on ototoxic medications was found to be an important contributing factor to the less than optimal ototoxicity management practices. Of factors potentially influencing adherence to guidelines, the institution of employment, specifically employment in a tuberculosis hospital, seemed to have a positive influence, possibly due to the focused nature of the audiologists’ scope of practice there as well as availability of resources. The level of education appeared to have no influence. Current findings provide contextually relevant evidence on ototoxicity assessment and management within this context. They raise important implications for guidelines adherence and translating knowledge, policies and guidelines into practice, clinical assessment and management protocols followed, appropriate resource allocation per programme, as well as strategic planning for national ototoxicity assessment and management programmes in context. The findings also raise important implications for low- and middle-income countries, in terms of adopting international guidelines without considering context.

Highlights

  • Ototoxicity is a reaction to the pharmaceutical drugs used to treat communicable diseases that affects the cochlea or auditory nerve, which is characterized by vestibular or cochlea dysfunction [1].The prevalence of medication-induced hearing loss has tripled over the years and this is attributed to increased usage of ototoxic-medications

  • Over two thirds of the participants engage with ototoxicity monitoring and management, but the practices adopted by them do not align with international standards nor with the national Health Professions Council of South Africa (HPCSA) guidelines on assessment and management of patients on ototoxic medications

  • In terms of whether the multidisciplinary approach is effective for ototoxicity assessment and management within the South African context, the results shown in Table 2 reveal that there are a number of barriers with the effective implementation of this approach

Read more

Summary

Introduction

The prevalence of medication-induced hearing loss has tripled over the years and this is attributed to increased usage of ototoxic-medications. Ototoxic medications play an important role in modern medicine; they have the capacity to cause significant morbidity [2]. This is problematic because one of the key challenges encountered in ototoxicity assessment and management is a delay in diagnosing ototoxicity; with diagnosis occurring too late when the hearing loss has become severe and affects the speech frequencies [1]. There are over 600 categories of medications that may cause ototoxicity, and this includes aminoglycosides antibiotics, platinum-based chemotherapeutic agents, loop diuretics, macrolide antibiotics and antimalarials [1]. Ototoxicity affects people of all ages, but it is problematic to document the global scale of its occurrence due to the varied research methodologies followed, especially in low and middle income (LAMI) countries; and the diverse criteria used to define ototoxicity

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call